In­dus­try groups call to block WTO IP waiv­er ex­pan­sion to Covid-19 ther­a­peu­tics

The WTO’s TRIPS Coun­cil in mid-Oc­to­ber is ex­pect­ed to de­bate whether to ex­tend the IP waiv­er for Covid-19 vac­cines to ther­a­peu­tics and di­ag­nos­tics too.

While the Biden ad­min­is­tra­tion backed the orig­i­nal vac­cine waiv­er, which crit­ics note has not done much to ex­pand ac­cess to vac­cines as de­mand has dried up, US trade of­fi­cials haven’t of­fered any per­spec­tive yet on whether to ex­pand the waiv­er to Covid treat­ments.

Endpoints News

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters